Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial
Titel:
Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial
Auteur:
Yang, James Chih-Hsin Shih, Jin-Yuan Su, Wu-Chou Hsia, Te-Chun Tsai, Chun-Ming Ou, Sai-Hong Ignatius Yu, Chung-Jen Chang, Gee-Chen Ho, Ching-Liang Sequist, Lecia V Dudek, Arkadiusz Z Shahidi, Mehdi Cong, Xiuyu Julie Lorence, Robert M Yang, Pan-Chyr Miller, Vincent A